Advertisement
U.S. Markets closed

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.6900+0.0300 (+1.81%)
At close: 04:00PM EDT
1.6905 +0.00 (+0.03%)
After hours: 07:52PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
174,497
194,623
292,484
211,650
294,644
Cost of Revenue
65,327
74,149
85,568
150,671
296,477
Gross Profit
109,170
120,474
206,916
60,979
-1,833
Operating Expense
144,265
166,549
271,762
325,481
375,993
Operating Income
-35,095
-46,075
-64,846
-264,502
-377,826
Net Non Operating Interest Income Expense
-7,475
-6,032
-15,687
-19,936
-8,871
Other Income Expense
2,128
182
-13,693
2,414
1,856
Pretax Income
-40,442
-51,925
-94,226
-282,024
-384,841
Tax Provision
-
-
0
0
0
Net Income Common Stockholders
-40,442
-51,925
-94,226
-282,024
-384,841
Diluted NI Available to Com Stockholders
-40,442
-51,925
-94,226
-282,024
-384,841
Basic EPS
-0.31
-0.28
-0.51
-1.70
-2.77
Diluted EPS
-0.31
-0.28
-0.51
-1.70
-2.77
Basic Average Shares
185,984
187,465
182,783
165,950
138,463
Diluted Average Shares
185,984
187,465
182,783
165,950
138,463
Total Operating Income as Reported
-35,322
-46,256
-80,779
-264,502
-377,826
Total Expenses
209,592
240,698
357,330
476,152
672,470
Net Income from Continuing & Discontinued Operation
-40,442
-51,925
-94,226
-282,024
-384,841
Normalized Income
-41,899
-51,220
-77,387
-282,024
-384,841
Interest Income
3,319
-
-
-
-
Interest Expense
7,475
6,032
15,687
19,936
8,871
Net Interest Income
-7,475
-6,032
-15,687
-19,936
-8,871
EBIT
-32,967
-45,893
-78,539
-264,502
-377,826
EBITDA
4,629
-8,266
-40,842
-226,532
-343,134
Reconciled Cost of Revenue
65,327
74,149
85,568
150,671
296,477
Reconciled Depreciation
37,596
37,627
37,697
37,970
34,692
Net Income from Continuing Operation Net Minority Interest
-40,442
-51,925
-94,226
-282,024
-384,841
Total Unusual Items Excluding Goodwill
1,457
-705
-16,839
0
0
Total Unusual Items
1,457
-705
-16,839
0
0
Normalized EBITDA
3,172
-7,561
-24,003
-226,532
-343,134
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0